Abstract
Glaucoma is the first cause of irreversible blindness worldwide. It is estimated up to 1.94 million inhabitants with glaucoma in our country. The glaucoma management faces several and severe issues, besides the fact that up to 80% of the patients worldwide does not comply with the pharmacological treatment. Based on that situation, a panel of experts analyzed the current glaucoma state of the art in Mexico and the advantages, limitations, and treatment alternatives. The academic coordinator distributed a Delphi questionnaire to the group. The studies of the patients that include the diverse indicated therapeutic options were mapped. The group analyzed the barriers and opportunities for implementing new treatments for glaucoma. They provided recommendations for improving the treatment and mitigate unmet needs. It is recommended to enhance the continuing medical education efforts on glaucoma in the general Ophthalmology services and promote early referral to the glaucoma experts to provide timely interventions, save resources, and improve both the treatment outcomes and the patients’ quality of life.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Latin american journal of clinical sciences and medical technology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
